DGAP-News: Carl Zeiss Meditec AG: Postponement of the Annual General Meeting 2020 in the course of tightening up the regulations for public events
|
DGAP-News: Carl Zeiss Meditec AG
/ Key word(s): AGM/EGM
Carl Zeiss Meditec AG: Postponement of the Annual General Meeting 2020 in the course of tightening up the regulations for public events
17.03.2020 / 10:38
The issuer is solely responsible for the content of this announcement.
| Carl Zeiss Meditec AG: Postponement of the Annual General Meeting 2020 in the course of tightening up the regulations for public events |
| |
JENA, 17 March 2020
On the basis of the decree of the President of the State Administration Office of Thuringia (Landesverwaltungsamt Thüringen) of 14 March 2020, according to which "events and meetings of people with 50 or more persons must be prohibited from now until further notice", the Management Board of Carl Zeiss Meditec AG has decided to postpone the Annual General Meeting, which was scheduled for Tuesday, 24 March 2020 (published in the Federal Gazette (Bundesanzeiger) of 11 February 2020); it will therefore not take place. A new date will be announced in time.
Contact for investors and press
Sebastian Frericks
Director Investor Relations, Carl Zeiss Meditec AG
Tel. 03641 220-116
E-Mail: [email protected]
www.zeiss.de/presse
17.03.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
|
| Language: |
English |
| Company: |
Carl Zeiss Meditec AG |
|
Göschwitzer Str. 51-52 |
|
07745 Jena, Germany |
|
Germany |
| Phone: |
+49 (0)3641 220-0 |
| Fax: |
+49 (0)3641 220-112 |
| E-mail: |
[email protected] |
| Internet: |
www.zeiss.de/meditec-ag/ir |
| ISIN: |
DE0005313704 |
| WKN: |
531370 |
| Indices: |
MDAX, TecDAX |
| Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: |
999125 |
| |
| End of News |
DGAP News Service |
999125 17.03.2020
|
Die wichtigsten Finanzdaten auf einen Blick
|
| |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023e |
| Umsatzerlöse1 |
1.189,90 |
1.280,86 |
1.459,32 |
1.335,45 |
1.646,79 |
1.902,84 |
2.089,30 |
| EBITDA1,2 |
205,07 |
228,41 |
313,03 |
237,98 |
435,20 |
466,65 |
422,19 |
| EBITDA-Marge3 |
17,23 |
17,83 |
21,45 |
17,82 |
26,43 |
24,52 |
|
| EBIT1,4 |
180,83 |
197,13 |
264,66 |
177,55 |
373,61 |
396,88 |
348,12 |
| EBIT-Marge5 |
15,20 |
15,39 |
18,14 |
13,30 |
22,69 |
20,86 |
16,66 |
| Jahresüberschuss1 |
135,78 |
126,23 |
160,58 |
123,42 |
237,52 |
295,91 |
292,01 |
| Netto-Marge6 |
11,41 |
9,86 |
11,00 |
9,24 |
14,42 |
15,55 |
13,98 |
| Cashflow1,7 |
37,73 |
187,21 |
219,63 |
178,53 |
362,66 |
188,20 |
250,86 |
| Ergebnis je Aktie8 |
1,57 |
1,41 |
1,79 |
1,37 |
2,64 |
3,29 |
3,25 |
| Dividende8 |
0,55 |
0,55 |
0,65 |
0,50 |
0,90 |
1,10 |
0,42 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen. 
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: PricewaterhouseCoopers
|
| INVESTOR-INFORMATIONEN |
| ©boersengefluester.de |
| Carl Zeiss Meditec |
| WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
| 531370 |
97,700 |
Halten |
8.738,34 |
| KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
| 27,52 |
35,03 |
0,79 |
47,89 |
| KBV |
KCV |
KUV |
EV/EBITDA |
| 4,24 |
34,83 |
4,18 |
18,63 |
| Dividende '22 in € |
Dividende '23e in € |
Div.-Rendite '23e
in % |
Hauptversammlung |
| 1,10 |
1,10 |
1,13 |
21.03.2024 |
| Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
| 09.02.2024 |
08.05.2024 |
06.08.2024 |
12.12.2023 |
| Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
| -11,47% |
1,63% |
-1,15% |
-19,82% |
|
|
Carl Zeiss Meditec AG DE0005313704